The future of healthcare is evolving with cutting-edge technology, as demonstrated by a live telerobotic surgery trial for emergency stroke treatment. This groundbreaking achievement was showcased during the Abu Dhabi Global Healthcare Week, where Dr Vitor Mendes Pereira successfully performed a mechanical thrombectomy procedure on a simulated patient in South Korea from Abu Dhabi. The procedure involved the timely removal of blood clots from the brain after a stroke, highlighting the potential for remote robotic surgery in the medical field.
The trial was conducted by XCath, an early-stage medical device company dedicated to expanding endovascular treatment robotic systems. Owned in part by Sharjah-based Crescent Enterprises, XCath aims to revolutionize healthcare through innovative robotic surgery solutions. Dr Pereira controlled the robotic operation using a robotic controller, while the silicone model and bedside unit were in Seoul. The neurovascular devices used included Stryker AXS Infinity LS, Trevo Trakb21, and Trevo NXT, with communication facilitated through standard conference Ethernet connection, with the possibility of 5G redundancy.
According to Eduardo Fonseca, CEO of XCath, the telerobotic procedure showcased the world’s first neurovascular robotic procedure, performed by Dr Pereira who is the director of Endovascular Research and Innovation at St Michael’s Hospital, University of Toronto, Canada. The successful removal of a clot using solely telerobotic means demonstrates the potential for remote robotic surgery to enhance medical care and accessibility for patients globally. Fonseca highlighted the significance of timely treatment for stroke patients, emphasizing the importance of democratizing care to save lives and reduce disability.
With strokes being a leading cause of death and disability worldwide, Fonseca stressed the need for advanced technologies like robotics to make life-saving treatments more accessible. The use of robotic surgery can bring medical care closer to patients, even in underdeveloped or remote areas, reducing the burden on healthcare systems globally. Fonseca revealed that the regulatory approvals for the first clinical case are expected next year, marking a significant milestone in the journey towards democratizing robotic surgery for emergency stroke treatment.
The live telerobotic surgery trial not only showcased the capabilities of robotic technology in healthcare but also shed light on the potential impact it could have on saving lives and reducing disability due to strokes. As XCath continues to innovate and advance in the field of robotic surgery, their vision of democratizing care through technology could transform the way emergency treatments are delivered globally. By making robotic surgery more accessible and efficient, the healthcare industry can potentially revolutionize emergency treatments and improve patient outcomes significantly.
